Literature DB >> 19487156

Mutation L33M in the HR1 region of HIV-1 gp41 may play a role in T20 resistance.

Huihui Chong1, Sihong Xu, Chuntao Zhang, Jianhui Nie, Youchun Wang.   

Abstract

BACKGROUND: Although Enfuvirtide (T20) has not been used in China, investigating the natural occurrence of primary resistance mutations in the HR1 region of the gp41 sequence from T20 naïve patients would help in determining treatment strategies for AIDS patients.
OBJECTIVES: To investigate natural mutations in the HR1 region of the gp41 sequence in China and evaluate their biological function. STUDY
DESIGN: The amino acid sequences in the HR1 region of 27 isolates including subtypes AE, BC and B' from Chinese T20 naïve patients were analyzed. All 27 isolates were constructed into pseudoviruses and their susceptibility to T20 was measured by using recombinant virus assays.
RESULTS: Mutations in a 10 amino acid motif, such as N42S and N42R, and those outside this motif, such as L33M, R46S, A50V, Q52H and L54M, were found in the 27 isolates. N in position 42 was mutated to S in all three AE subtype strains and 17 of 18 subtype BC strains, whilst it was mutated to R in all 6 subtypes B strains. Compared to the SF162 strain, the susceptibility of the mutants, except for L33M, to T20 was not significantly different. After L was mutated to M in position 33 of six strains by site directed mutagenesis, their IC50 values were increased by 3.7-7.9-fold.
CONCLUSIONS: Mutations outside a 10 amino acid motif in HR1, such as L33M, may cause T20 resistance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19487156     DOI: 10.1016/j.jcv.2009.05.001

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  8 in total

1.  Discovery of critical residues for viral entry and inhibition through structural Insight of HIV-1 fusion inhibitor CP621-652.

Authors:  Huihui Chong; Xue Yao; Zonglin Qiu; Bo Qin; Ruiyun Han; Sandro Waltersperger; Meitian Wang; Sheng Cui; Yuxian He
Journal:  J Biol Chem       Date:  2012-04-16       Impact factor: 5.157

2.  DNA duplexes with hydrophobic modifications inhibit fusion between HIV-1 and cell membranes.

Authors:  Liang Xu; Lifeng Cai; Xueliang Chen; Xifeng Jiang; Huihui Chong; Baohua Zheng; Kun Wang; Junlin He; Wei Chen; Tao Zhang; Maosheng Cheng; Yuxian He; Keliang Liu
Journal:  Antimicrob Agents Chemother       Date:  2013-07-29       Impact factor: 5.191

3.  DNA Triplex-Based Complexes Display Anti-HIV-1-Cell Fusion Activity.

Authors:  Liang Xu; Tao Zhang; Xiaoyu Xu; Huihui Chong; Wenqing Lai; Xifeng Jiang; Chao Wang; Yuxian He; Keliang Liu
Journal:  Nucleic Acid Ther       Date:  2015-08       Impact factor: 5.486

4.  Mechanism of HIV-1 Resistance to Short-Peptide Fusion Inhibitors Targeting the Gp41 Pocket.

Authors:  Yang Su; Huihiui Chong; Zonglin Qiu; Shengwen Xiong; Yuxian He
Journal:  J Virol       Date:  2015-03-18       Impact factor: 5.103

5.  Biophysical property and broad anti-HIV activity of albuvirtide, a 3-maleimimidopropionic acid-modified peptide fusion inhibitor.

Authors:  Huihui Chong; Xue Yao; Chao Zhang; Lifeng Cai; Sheng Cui; Youchun Wang; Yuxian He
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

6.  Assessment of Antibody Interference of Enfuvirtide (T20) Function Shows Assay Dependent Variability.

Authors:  Michele Smith; Jonathon Hoffman; Hakimuddin Sojar; Ravikumar Aalinkeel; Chiu-Bin Hsiao; Mark Daniel Hicar
Journal:  Curr HIV Res       Date:  2018       Impact factor: 1.581

Review 7.  HIV-1 pseudoviruses constructed in China regulatory laboratory.

Authors:  Jianhui Nie; Weijin Huang; Qiang Liu; Youchun Wang
Journal:  Emerg Microbes Infect       Date:  2019-12-20       Impact factor: 7.163

Review 8.  Current status on the development of pseudoviruses for enveloped viruses.

Authors:  Qianqian Li; Qiang Liu; Weijin Huang; Xuguang Li; Youchun Wang
Journal:  Rev Med Virol       Date:  2017-12-07       Impact factor: 6.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.